Introduction
Renal transplantation is the treatment of choice for patients with end-stage renal disease (ESRD) and improves their long-term survival. However, the number of potential kidney transplant recipients has grown much faster than the number of kidneys available. Therefore, alternative sources of organs are being explored including donation after cardiac death (DCD) and paediatric donation.
Historically, DCD was the primary donor source in clinical transplantation. Since brain death was defined in 1968, the vast majority of donor organs have been procured by donation after brain death (DBD) with the advantage that the period of warm ischaemia is reduced to a minimum [1, 2] . However, owing to the disparity between available donor kidneys and patients on the waiting list, a renewed interest in DCD has developed. DCD donors usually experience a variable period of hypotension followed by a complete lack of perfusion from the time of circulatory arrest to the start of intravascular cooling. These periods of ischaemia affect the outcome of transplanted grafts. Nevertheless, long-term graft and patient survival have been reported to be similar among kidneys transplanted after DCD and DBD [3] [4] [5] .
Another way to expand the donor pool is procuring organs from 'paediatric' donors. However, transplantation of paediatric donor kidneys is associated with higher complication rates such as early graft failure due to graft thrombosis, early rejection and hyperfiltration injury [6] [7] [8] . The United Network of Organ Sharing shows that paediatric donor kidneys from donors younger than 18 years of age have a small but significantly worse outcome than adult kidneys [9] . Still, the outcome was acceptable considering the alternative of prolonging dialysis treatment.
The ethical aspects of paediatric DCD are extensively described; nevertheless, the literature on outcomes of paediatric DCD kidney transplantation is scanty [10] . No studies comparing DCD and DBD in paediatric kidney transplantation are available. Therefore, we examined whether additional ischaemic damage influences the outcome of transplanted paediatric kidneys. We report the results of paediatric DCD compared with paediatric DBD transplantation in the Netherlands over a 25-year time period. Short-and medium-term graft function, as well as long-term graft-and patient survival, were compared between groups.
Materials and methods

Study design and data source
All patients with ESRD who received a kidney from a deceased paediatric donor in one of all seven Dutch transplant centres between January 1981 and July 2006 were reviewed retrospectively. Kidneys were procured from 'controlled' donors after withdrawal of treatment (category 3) and from 'uncontrolled' donors after stop of resuscitation (category 2), according to the Maastricht criteria [11] . We have described the technique of organ procurement in detail previously [12] [13] [14] . Procurement techniques include in situ preservation with a double-balloon triple lumen catheter or direct cannulation of the aorta by laparotomy. Both these techniques are performed after a no-touch period of at least 5 min in which no resuscitation took place or invasive or medical treatment was given. In the early study period (1981-89), both DCD and DBD kidneys were preserved with Eurocollins solution, and thereafter, DCD kidneys were predominantly preserved with histidine tryptophan ketoglutarate and DBD kidneys with University of Wisconsin preservation fluid. DBD kidneys were stored on ice. DCD kidneys donated in Maastricht were machine preserved (n = 12). The results were compared with the results of all paediatric DBD kidney recipients in the Netherlands in the same time period.
Immunosuppressive therapy
The immunosuppressive regimen evolved over the study period as different trials were conducted. Immunosuppression was based mainly on a combination of a calcineurin inhibitor and prednisolone. Depending on the protocol at the time, these were combined with azathioprine, mycophenolate mofetil, sirolimus or daclizumab in recipients with an increased immunological risk (e.g. HLA immunization and retransplants). Patients with mild-to-moderate rejection were given prednisolone; vascular and steroid-resistant rejections were treated with anti-thymocyte globulins.
Patients
Data for this observational study were collected from the Dutch organ transplant registry (NOTR). Recipients from DCD and DBD donors <18 years of age transplanted between January 1981 and July 2006 were included in this study. Follow-up ended 1 January 2007. Donor, graft and recipient characteristics were prospectively documented. The glomerular filtration rate (GFR) of the donor was estimated by the Counahan Barrett formula, used to estimate GFR in children [15] . The following graft characteristics were recorded: warm ischaemia time, the time from circulatory arrest (category 3 donors) or stop of resuscitation (category 2 donors) until the initial cold flush of the kidneys; cold ischaemia time, the period between the initial flush and the start of first anastomosis of the recipient operation and the anastomosis period, the time to complete both vascular anastomoses. Circulatory arrest was diagnosed after cessation of heart beat and the absence of an arterial pulse.
Short-term graft function after transplantation was classified as (i) primary non-function (PNF): inadequate renal function necessitating continuation of dialysis or retransplantation; (ii) delayed graft function (DGF): renal function that was ultimately life sustaining but required temporary dialysis after transplantation within 1 week of transplantation and (iii) immediate function (IF): immediate renal function without the need of post-operative dialysis. The recipients were followed up for GFR (which was estimated by the abbreviated MDRD formula for the adult recipients [16] ) and for graft and patient survival. GFR was reported 3 months after transplantation and yearly thereafter. Allograft failure date was defined as the date of return to dialysis.
The mean follow-up time was 8.1 years, and 18% of patients were lost to follow-up (13% in the DCD group and 19% in the DBD group). Short-term outcome, graft function and graft-and patient survival of DCD kidney transplants were compared with DBD kidney transplants.
Statistical analysis
Continuous variables were presented as mean ± standard deviation if normally distributed, and as median and range otherwise. Categorical variables were presented as percentages. Baseline characteristics between groups were compared with Student's t-test for normally distributed continuous variables, with the Mann-Whitney U-test if the distribution was not normal and with Pearson's Chi-square test for categorical variables. Comparison of the outcome measures (PNF and DGF) between groups was performed with correction for potential confounders in multivariable regression models. First, each characteristic with P < 0.20 was added separately to a univariable regression model. Second, for PNF and DGF, two and six variables, respectively, with lowest P-values in the univariable regression analyses were added to a multivariable model to study associations with the outcome measures. Continuous variables were categorized by cut offs to meet linearity assumptions. All the variables were tested for multicollinearity. Graft and patient survival were compared between groups by a multivariable Cox regression analysis. The incidence of DGF and PNF in both DCD and DBD kidney transplantation groups was compared with exclusion from pre-emptive transplanted patients because short-term graft function cannot be determined as DGF or IF as formulated. The aforementioned multivariable model was repeated for PNF and for GFR but as a linear regression; recipients with PNF were excluded from this analysis. Log-rank tests were performed to compare graft and patient survival between the DCD and the DBD groups. A P-value of < 0.05 was considered statistically significant. Statistical analysis was performed with SPSS for Windows version 15.0.
Ethics
Collection, storage and use of patient data were performed in agreement with the code of conduct 'Use of data in health research' put forward by 'The federation of Dutch medical scientific societies' (http://www.federa. org/).
Results
Between January 1981 and July 2006 496, patients with ESRD received a paediatric donor kidney in the Netherlands, 91 received a graft from a DCD donor and 405 recipients were transplanted with kidneys from DBD donors. Twelve percent of the DCD kidneys were from Maastricht category 2: uncontrolled donors after unsuccessful resuscitation.
Donor, graft and recipient characteristics are shown in Table 1 . In both groups, a small percentage of the recipients received two kidneys from one donor; their kidneys were transplanted en bloc [DCD 2 (2%), DBD 5 (1%)]. The mean donor age was 14 years in the DCD group and 13 years in the DBD group, with 11 (12%) and 41 (10%) donors under the age of 6 years, respectively (P = 0.62). The mean year of transplantation was later in the DCD group than in the DBD group, 2001 versus 1994, respectively, P < 0.001. For DCD donors, the average warm ischaemia time was 23 min, whereas for DBD donors this period of warm ischaemia was close to 0. The cold ischaemia time was shorter in the DCD group than in the DBD group, 22 ± 5 versus 24 ± 8 h (P = 0.01) and recipients of DCD kidneys were older than DBD kidney recipients, 50 ± 15 versus 40 ± 18 years (P < 0.01), respectively. Among recipients in the DCD group, a significantly higher percentage of patients had panel reactive antibodies ≥5 (n = 6, 7%) than in the DBD group (n = 66, 17%) (P = 0.01). Recipients from DCD kidneys were 1.6 years longer on dialysis, resulting in a mean period of 3.9 ± 2.3 years on the waiting list before transplantation. Immunosuppressive regimen, use of induction therapy (P ≤ 0.001), mycophenolate mofetil (P ≤ 0.001) and use of cyclosporine or tacrolimus (P = 0.01) differed significantly between groups.
Short-term graft function
The short-term outcome of transplantation in the two groups is shown in Table 2 . The DCD group, compared with the DBD group, showed a higher percentage of PNF (n = 8, 9 versus n = 8, 2%, P < 0.01). The cause of PNF in the DCD and DBD group was thrombosis (DCD: n = 4, 50%; DBD: n = 6, 88%), technical surgical problems (DCD: n = 3, 38%; DBD: n = 1, 13%) and unknown (DCD: n = 1, 13%; DBD: 0%), and was not significantly different between groups (P = 0.28). In a multivariable logistic regression model, donor type (DCD) and donor age younger than 10 years were independent predictors of PNF with an odds ratio (OR) of 5.837 [95% confidence interval (CI) 2.040-16.689; P = 0.001] and 4.621 (95% CI 1.616-13.216; P = 0.004), respectively (Table 3 ). Survival of patients receiving grafts with PNF was not significantly different from recipients of functioning grafts (80 versus 86% after 5 years, respectively; P = 0.41). An additional univariable analysis within the DCD group showed that donor age ≤5 years is significantly associated with PNF (P = 0.035). The proportion of DCD transplantation increased over time. As the quality of DCD transplantation may have improved, we performed a univariable sub analysis for the era 2000-06. Also in this era the OR suggests that there is an association between donor type (DCD) and PNF [OR 3.322 (CI 0.359-30.704, P = 0.290)], but it did not reach significance. Also DGF occurred more often in the DCD group compared with the DBD group (48 versus 8%, P < 0.001). Donor type (DCD), warm ischaemia time and cold ischaemic time were independent predictors of DGF with an OR of 7.709 (95% CI 2.342-25.380; P = 0.001), 1.053 (95% CI 1.011-1.098; P = 0.014), and 1.092 (95% CI 1.045-1.142; P < 0.001), respectively. The mean duration of post-operative dialysis after transplantation in patients with DGF was 13 days in the DCD group and 9 days in the DBD group (P = 0.03).
Long-term graft function
Graft function of functioning grafts assessed with multivariable linear regression analysis did not differ between the DCD and the DBD groups [48 ± 20 versus 53 ± 21 mL/min (P = 0.35) at 3 months and 62 ± 14 versus 57 ± 22 mL/min (P = 0.26) at 5 years] (Table 4) .
Death-censored graft survival in the DCD and the DBD groups was 84 and 88% after 1 year and 78 and 80% after 5 years, respectively ( Figure 1A ). Overall 1-year graft survival was 83% in the DCD group and 85% in the DBD group; overall 5-year graft survival was 72% in both groups. After correction for confounding variables (donor age, transplantation year, cold ischaemic time, recipient age and immunosuppressive regimen), the rate of death-censored graft failure was higher in the DCD group [hazard ratio 2.440 (95% CI 1.280-4.650; P = 0.007)] (Table 5) . Donor age under 10 years was significantly associated with graft failure [hazard ratio 2.051 (95% CI 1.393-3.019; P < 0.001)]. Patient survival in the DCD and the DBD groups was 95% in both groups at 1 year, and 87% in the DCD and 86% in the DBD group at 5 years ( Figure 1B) . Also after correction for confounding variables, donor type was not associated with patient survival [hazard ratio 1.559 (95% CI 0.848-2.867; P = 0.153)] (Table 5) .
Without correction for confounding variables, log-rank tests comparing graft and patient survival between the DCD and the DBD groups did not show a statistical difference (P = 0.590 and 0.717), respectively. Categorical values are presented as number and continues values as mean ± SD; the given odds ratio refers to the first mentioned category. 
Discussion
We present the results of kidney transplantation in a consecutive series of 496 recipients of paediatric DCD and DBD donors, during a period of 25 years. This study is the first to compare paediatric DCD and DBD kidneys, using multivariable regression analyses. Transplant recipients benefit from a superior life expectancy and improvement in quality of life compared with patients on dialysis treatment [17] [18] [19] . With the current shortage of organs for transplantation, attention has been directed towards expanding the donor pool with less traditionally used organs including organs from paediatric donors and organs from donors after cardiac death. DCD donors have become an important source of donor kidneys and currently represent up to 50% of all deceased donors in the Netherlands. Patient survival and graft survival of functioning grafts is similar to DBD donor kidneys [3] . Transplantation of paediatric DCD kidneys lags behind as the outcome is relatively unknown.
To assess the effect of warm ischaemic injury on paediatric donor kidneys, graft function and long-term graft and patient survival were compared between paediatric DCD and DBD kidney transplantation. Acceptable outcomes of paediatric DCD kidneys were obtained despite the higher percentage of PNF and DGF, as well as a higher rate of graft failure in the DCD group. In this study, we reported a 5-year graft survival rate of 78% in the paediatric DCD group versus 80% in the paediatric DBD group. These survival rates are comparable with results of adult DCD and DBD transplantation, in which 5-year death-censored graft survival rates of 63-83% for DCD transplantation and 71-84% for DBD transplantation are reported [4, [20] [21] [22] [23] .
The incidence of PNF was higher in DCD kidneys than in DBD kidneys. In both groups, graft thrombosis was the most common cause of early graft loss. Small donor kidneys particularly from young donors with low initial flow are at increased risk for graft thrombosis and worse outcome [24] . This risk is aggravated by ischaemia reperfusion injury caused by warm ischaemia in DCD kidneys. Inflammatory response and oedema jeopardize adequate graft perfusion with consequent low flow and graft thrombosis. Furthermore, the anastomoses of small paediatric donor vessels with the relatively large vessels may be a surgical challenge, particularly for kidneys from very young donors [7, 9] . This also gives an increased risk of graft thrombosis, but counts for both DCD and DBD groups. However, this combined etiology of graft thrombosis makes it extremely difficult to identify a definite cause for graft thrombosis in the individual patient and in particular for DCD donor kidneys. We indeed found that Graft survival is death censored. In case of categorical variables, the given odds ratio refers to the first mentioned category.
donor age below 10 years is an independent predictor of PNF; however, a cut off age to simplify the decision, which DCD kidney should be transplanted and which not, could not be assessed. To improve the results of paediatric donor kidney transplantation, en bloc transplantation can be performed if the donor is below a certain age or weight [9] . DGF occurred significantly more often in the DCD group and the period of DGF lasted longer. This is consistent with historical outcomes of adult DCD kidney transplantation [4, 5] . The long-term graft survival of paediatric DCD grafts with DGF was similar to the graft survival of grafts with immediate function, which is also consistent with studies in adult donors [25] . This finding implies that DGF has no effect on the long-term outcome of DCD kidneys, while in DBD kidneys DGF is associated with worse long-term outcome and a higher incidence of chronic rejection [26, 27] .
The incidence of PNF of kidneys from paediatric DCD donors was relatively high and the quality of these kidneys may therefore be considered less than optimal. However, the alternative, treatment of continuing dialysis therapy until an optimal donor kidney is offered, is associated with a high mortality rate [28] . Indeed, kidneys from adult DCD donors provide a survival benefit compared with standard treatment, even though 12% of the kidneys failed in the first 3 months after transplantation. Furthermore, graft survival of kidneys from paediatric DCD donors that survive the immediate post-transplant period is excellent [9, 29, 30] .
Paediatric DCD programmes may expand the donor pool substantially because withdrawal of life-sustaining treatment is a common setting in paediatric intensive care units (PICU). A review of literature reveals that 40-65% of deaths occurring in European PICUs follow withdrawal of treatment [31] , which is up to three times as much as the percentage of children who die after brain death. Although this percentage of planned withdrawals of treatment overestimates the number of potential DCD donors, routine use of the paediatric DCD donor has the ability to significantly increase organ donation [32] . There are ethical and practical considerations that may discourage centres to start paediatric DCD programmes. We have described these issues before [12, 33] . However, we showed that graft and patient survival using paediatric DCD kidneys are encouraging.
We conclude that paediatric DCD represents a valuable source of kidneys that has not been fully utilized. More widespread implementation of paediatric DCD programmes may further increase the life expectancy of patients with ESRD in an era of kidney donor shortage.
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